Brendon Yee, PhD, professor and respiratory and sleep physician, Woolcock Institute of Medical Research, discusses the ...

Imagine repeatedly falling asleep or falling down paralyzed when laughing or startled. This is life with narcolepsy, which ...

Orexin, also known as hypocretin, is a brain hormone that helps regulate sleep. A deficiency of this hormone can cause a person to develop type 1 narcolepsy. Type 1 narcolepsy, formerly known as ...

New research links childhood adversity with later attention deficits, sleep disruptions, and specific dopamine imbalances in ...

Stifel upgraded Alkermes (ALKS) to Buy from Hold with a price target of $36, up from $25. After a deep dive on the orexin space, the firm says ...

With the potential to be a first-in-class drug, seltorexant is a potent, selective orexin-2 receptor antagonist that ...

CVN293 was generally well-tolerated in healthy volunteers for up to 14-days of continuous dosingDose-dependent exposure was observed with ...

The stocks for both Swiss and Israeli biotechs were up over 20% after the companies signed a merger agreement.

NLS Pharmaceutics shares are moving higher on Monday after the company announced it entered into a definitive merger ...

Goldman Sachs lowered the firm’s price target on Alkermes (ALKS) to $30 from $32 and keeps a Buy rating on the shares. The ...

ZURICH, SWITZERLAND and NESS ZIONA, ISRAEL / ACCESSWIRE / November 4, 2024 / Ltd. (NASDAQ:NLSP) ("NLS"), a biopharmaceutical ...

Researchers have looked at the potential roles of neurotransmitters in the brain and cerebrospinal fluid including hypocretin ...